Matthew D. Dallas, Chief Financial Officer at CoLucid Pharmaceuticals, Inc. (CLCD), sold 2,946 shares at $36.25 ($107K) on 2017-01-03, disclosed to the SEC on 2017-01-04.
Open-market sale of $107k CLCD by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.25 | 1,473 | $53K | 50.0% |
| 2 | $36.25 | 1,473 | $53K | 50.0% |
| Total | $36.25 avg | 2,946 | $107K | 100% |
| Filing → |
| AVEO | SELL | 2015-01-08 | $415 | — | Filing → |